OXALATE RETENTION IN END-STAGE RENAL-FAILURE (ESRF) - HEMODIALYSIS (HD) VS CHRONIC AMBULATORY PERITONEAL-DIALYSIS (CAPD) AND THE EFFECTS OF ASCORBIC-ACID AND PYRIDOXINE

被引：1
|
作者：
MORGAN, SH
PURKISS, P
MAHER, ER
WATTS, RWE
CURTIS, JR
机构：
[1] CLIN RES CTR,HARROW HA1 3UJ,MIDDX,ENGLAND
[2] CHARING CROSS HOSP,DEPT MED,LONDON W6 8RP,ENGLAND
来源：
CLINICAL SCIENCE | 1987年 / 73卷
关键词：
D O I：
10.1042/cs073041Pc
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：P41 / P41
页数：1
相关论文
共 50 条
  • [41] TREATMENT OF END-STAGE RENAL-FAILURE DUE TO DIABETES-MELLITUS WITH PERITONEAL-DIALYSIS - TREATMENT OF CHOICE
    PLAKSIN, J
    BONER, G
    ROSENFELD, JB
    REVUE ROUMAINE DE MEDECINE-MEDECINE INTERNE, 1982, 20 (04): : 283 - 288
  • [42] ALTERATION OF PITUITARY-THYROID FUNCTION IN PATIENTS WITH CHRONIC RENAL-FAILURE TREATED BY HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    ROSS, RJM
    GOODWIN, FJ
    HOUGHTON, BJ
    BOUCHER, BJ
    ANNALS OF CLINICAL BIOCHEMISTRY, 1985, 22 (MAR) : 156 - 160
  • [43] COMPARISON OF THE EFFECTS OF MUZOLIMINE AND FUROSEMIDE IN PATIENTS WITH END-STAGE RENAL-FAILURE ON CHRONIC DIALYSIS
    SCHMIDT, P
    LOEW, D
    DYCKA, J
    KOPSA, H
    BALCKE, P
    ZAZGORNIK, J
    DEUTSCH, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (01) : 23 - 26
  • [44] Risk of hemodialysis against peritoneal dialysis for chronic heart failure in patients with end-stage renal disease
    Kawada, Tomoyuki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 360 - 360
  • [45] THE USE OF CONTINUOUS PERITONEAL-DIALYSIS IN EUROPE FOR THE TREATMENT OF CHILDREN WITH END-STAGE RENAL-FAILURE - DATA FROM THE EDTA REGISTRY
    RIZZONI, G
    BROYER, M
    EHRICH, JHH
    SELWOOD, NH
    BRUNNER, FP
    BRYNGER, H
    DYKES, SR
    FASSBINDER, W
    GEERLINGS, W
    TUFVESON, G
    WING, AJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (12) : 985 - 990
  • [46] ACID-BASE STATUS OF ADULTS WITH END-STAGE RENAL-DISEASE TREATED BY CHRONIC PERITONEAL-DIALYSIS
    GOODKIN, DA
    RAJA, RM
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 246 - 246
  • [47] BEHAVIOR OF BETA-2-MICROGLOBULIN IN PATIENTS WITH CHRONIC-RENAL-FAILURE UNDERGOING HEMODIALYSIS, HEMODIAFILTRATION AND CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD)
    BLUMBERG, A
    BURGI, W
    CLINICAL NEPHROLOGY, 1987, 27 (05) : 245 - 249
  • [48] THE INCIDENCE OF DYSLIPOPROTEINEMIA IS INCREASED IN CHILDREN WITH END-STAGE RENAL-DISEASE (ESRD) TREATED WITH PERITONEAL-DIALYSIS (PD) VERSUS HEMODIALYSIS (HD)
    HEILICZER, JD
    KUIZON, BD
    OSORIO, MA
    CLARDY, CW
    PEDIATRIC RESEARCH, 1994, 35 (04) : A366 - A366
  • [49] A COMPARISON OF EMPLOYMENT RATES OF PATIENTS TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS VS IN-CENTER HEMODIALYSIS (MICHIGAN END-STAGE RENAL-DISEASE STUDY)
    JULIUS, M
    KNEISLEY, JD
    CARPENTIERALTING, P
    HAWTHORNE, VM
    WOLFE, RA
    PORT, FK
    ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (04) : 839 - 842
  • [50] MULTICENTER STUDY OF LIPOPROTEIN(A) AND APOLIPOPROTEIN(A) PHENOTYPES IN PATIENTS WITH END-STAGE RENAL-DISEASE TREATED BY HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    KRONENBERG, F
    KONIG, P
    NEYER, U
    AUINGER, M
    PRIBASNIG, A
    LANG, U
    REITINGER, J
    PINTER, G
    UTERMANN, G
    DIEPLINGER, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (01): : 110 - 120
12345